Capital Impact Advisors, LLC Eagle Pharmaceuticals, Inc. Transaction History

Capital Impact Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$17.74 - $31.87 $204,524 - $367,429	11,529 Added 84.73%	25,136 $488,000
Q1 2023 May 23, 2023	BUY	$25.06 - $34.09 $22,629 - $30,783	903 Added 7.11%	13,607 $386,000
Q3 2022 Nov 21, 2022	BUY	$26.42 - $47.12 $25,785 - $45,989	976 Added 8.32%	12,704 $465,000
Q2 2022 Aug 15, 2022	SELL	$41.26 - $51.35 $172,879 - $215,156	-4,190 Reduced 26.32%	11,728 $521,000
Q1 2022 May 16, 2022	SELL	$44.58 - $52.6 $149,699 - $176,630	-3,358 Reduced 17.42%	15,918 $788,000
Q2 2021 Aug 17, 2021	SELL	$36.86 - $44.5 $609,627 - $735,985	-16,539 Reduced 46.18%	19,276 $825,000
Q1 2020 May 15, 2020	BUY	$34.37 - $60.07 $71,833 - $125,546	2,090 Added 6.2%	35,815 $1.65 Million
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $75,828 - $85,411	-1,424 Reduced 4.05%	33,725 $1.9 Million
Q2 2019 Jul 19, 2019	BUY	$46.61 - $58.45 $56,398 - $70,724	1,210 Added 3.57%	35,149 $1.93 Million
Q4 2018 Mar 08, 2019	BUY	$36.72 - $67.73 $361,875 - $667,479	9,855 Added 40.92%	33,939 $1.33 Million
Q2 2018 Jul 25, 2018	SELL	$51.25 - $76.62 $114,441 - $171,092	-2,233 Reduced 8.49%	24,084 $1.83 Million
Q1 2018 Apr 11, 2018	BUY	$52.16 - $66.86 $1.37 Million - $1.76 Million	26,317 New	26,317 $1.39 Million

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.